FDA Opens Early Access to Novel Pancreatic Cancer Drug Generating Buzz

(MedPage Today) — The FDA has given the green light to an expanded access program (EAP) for the investigational pancreatic cancer drug daraxonrasib. In a “safe” letter to Revolution Medicines, the FDA gave approval to launch…